NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate
NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate
NRX Pharmicals第一季度每股收益美元(0.74美元)未達到預期(0.37美元)
NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.37) by 100 percent. This is a 53.75 percent increase over losses of $(1.60) per share from the same period last year.
NRX Pharmicals(納斯達克股票代碼:NRXP)公佈的季度虧損爲每股0.74美元,比分析師普遍預期的0.37美元(0.37美元)低100%。這比去年同期每股虧損1.60美元(1.60美元)增長了53.75%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。